文献速递免疫规划妇幼与学校卫生

纽约市公立学校学生HPV疫苗接种状况与残障状况的差异分析

Does human papillomavirus vaccination status differ by disability status in New York city public schools?
PubMed 文献 · Vaccine · 2026-03-04

该横断面分析纳入2022-23学年纽约市公立学校13-21岁学生365,167人,利用官方疫苗接种记录和个别化教育计划(IEP)状态,评估自闭症、智力障碍(ID)或其他IEP状况学生与非IEP学生相比HPV疫苗接种的差异,并以COVID-19疫苗接种作为对照结局。结果显示,自闭症学生接种HPV疫苗的可能性较低(aPR 0.89,99% CI 0.88, 0.91),ID学生与非IEP学生相似(aPR 1.02,99% CI 1.00, 1.04),而COVID-19疫苗接种在各IEP状态间无差异。研究提示需对纽约市公立学校自闭症青少年开展针对性HPV疫苗宣教。

要点

  • 自闭症学生接种HPV疫苗可能性低于无IEP学生(aPR 0.89,99% CI 0.88, 0.91)。
  • 智力障碍学生HPV疫苗接种率与无IEP学生相似(aPR 1.02,99% CI 1.00, 1.04)。
  • COVID-19疫苗接种在各IEP状态间无差异,提示差异具疫苗特异性。

核心结论

  • 纽约市公立学校自闭症青少年HPV疫苗接种率低于无IEP学生,而智力障碍学生与无IEP学生相似。
  • COVID-19疫苗接种在各IEP状态间无差异,提示HPV疫苗差异并非普遍接种障碍所致。

研究设计与样本

  • 横断面分析纳入2022-23学年纽约市公立学校所有13-21岁学生365,167人。
  • 利用官方疫苗接种记录和个别化教育计划(IEP)状态评估残障状况。
  • 采用多变量泊松回归估计调整患病率比(aPR),调整社会人口学特征。

主要发现

  • 样本中2.5%有自闭症,0.9%有智力障碍,19.2%有其他IEP状况。
  • 80.5%学生至少接种一剂HPV疫苗,70.8%接种一剂COVID-19疫苗。
  • 自闭症学生接种HPV疫苗的aPR为0.89(99% CI 0.88, 0.91),低于无IEP学生。
  • 智力障碍学生接种HPV疫苗的aPR为1.02(99% CI 1.00, 1.04),与无IEP学生相似。
  • COVID-19疫苗接种在各IEP状态间无差异。

临床怎么用

  • 对纽约市公立学校自闭症青少年开展针对性HPV疫苗外展和教育。
  • 未来研究应评估该人群HPV疫苗接种的障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High rates of human papillomavirus (HPV) vaccination could eliminate cervical cancer and reduce other HPV-related morbidity. Studies outside of the United States (US) have found lower HPV vaccine uptake among adolescents with Autism and/or intellectual disability (ID) than their peers. This cross-sectional analysis of all 2022-23 New York City (NYC) public school students aged 13-21 used official vaccination records and Individual Educational Plan (IEP) statuses to assess whether HPV vaccination differed for students with Autism, ID, or other IEP conditions compared to no IEP, with COVID-19 vaccination as a control outcome. We used multivariable Poisson regression to estimate adjusted prevalence ratios (aPR) for vaccination status by disability, adjusting for sociodemographic characteristics. The sample comprised 365,167 students; 2.5% had Autism, 0.9% ID and 19.2% another IEP status. In total, 80.5% had received at least one dose of the HPV vaccine and 70.8% one dose of the COVID-19 vaccine. Students with Autism were less likely (aPR 0.89, 99% CI 0.88, 0.91) and students with ID were as likely (aPR 1.02, 99% CI 1.00, 1.04) to have received an HPV vaccine as those with no IEP, with no differences by IEP status for COVID-19 vaccination. Targeted outreach and education on the HPV vaccine is needed for adolescents with Autism in NYC public schools. Future research should assess barriers to HPV vaccination among this population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lyons AJ, Mhatre MM, Argenio K, et al. Does human papillomavirus vaccination status differ by disability status in New York city public schools? Vaccine. 2026. PMID: 41785680. doi:10.1016/j.vaccine.2026.128404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。